|
|
| Begins |
September 20, 2004
|
|
|
|
|
|
|
|
| Email |
sgelfand@iirusa.com
|
|
| Category |
Health: Insurance
|
|
|
|
|
|
|
|
|
|
|
|
| Description |
The prominence of issues plaguing pharmaceutical manufacturers and states seem to have reached a pinnacle. The struggle between the pharmaceutical industry’s innovative R & D goals and state governments’ budget cuts have resulted in more challenges surrounding the Medicaid Drug Rebate Program than ever before.
Over the past eight years, IIR’s conference on the MDRP has been providing states and manufacturers with best practices in managing the increasingly complex set of rebate responsibilities and avoiding disputes, while maintaining compliance with federal regulations. As the atmosphere has become ever more complex, our mission has evolved to address ongoing legislative action, changes, and ongoing litigation faced by state governments and pharmaceutical manufacturers as they administer the federally mandated Medicaid Drug Rebate Program. In addition, the event delivers legislative and regulatory Medicaid rebate and pricing policy updates as well as solutions to compliance challenges on a federal level.
|
|
|
|
